Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation.

Authors:
Yang M; Xia L; Song J; Hu H; Zang N and 10 more

Journal:
Lipids Health Dis

Publication Year: 2023

DOI:
10.1186/s12944-023-01969-y

PMCID:
PMC10668385

PMID:
38001459

Journal Information

Full Title: Lipids Health Dis

Abbreviation: Lipids Health Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nutrition & Dietetics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateAll experiments and treatments on mice were in accordance with the International Guidelines for the Use of Laboratory Animals. The experimental animal protocols received the acceptance of the Ethics Committee of Shandong University (permission number: SYXK20190005). Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This study was supported by the National Natural Science Foundation of China (82070800), Special fund for Taishan industrial leading talent project, and Major basic research project of Shandong Natural Science Foundation (ZR2022ZD15)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025